gentamicin has been researched along with Hematologic Malignancies in 8 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetics (PK) of isepamicin were studied in 8 febrile neutropenic patients with hematologic malignancy and in 20 young women with acute pelvic inflammatory disease (PID)." | 9.11 | Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease. ( Gala, JL; Leal, T; Vandercam, B; Wallemacq, P; Yombi, JC, 2005) |
| "During a 12-month study, 42 adult patients with febrile neutropenia (granulocytes < 1 x 10(9)/l) were treated with once-daily gentamicin (5 mg/kg)." | 7.69 | Audit of once-daily dosing gentamicin therapy in neutropenic fever. ( Cooke, RP; Gover, PA; Grace, RJ, 1997) |
| "The pharmacokinetics (PK) of isepamicin were studied in 8 febrile neutropenic patients with hematologic malignancy and in 20 young women with acute pelvic inflammatory disease (PID)." | 5.11 | Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease. ( Gala, JL; Leal, T; Vandercam, B; Wallemacq, P; Yombi, JC, 2005) |
| " If fever persisted, teicoplanin plus gentamicin (group A) or teicoplanin plus ciprofloxacin (group B) were added." | 5.10 | Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. ( Fixson, A; Glasmacher, A; Gorschlüter, M; Hahn, C; Horré, R; Marklein, G; Mey, U; Molitor, E; Sauerbruch, T; Schmidt-Wolf, IG; Ziske, C, 2003) |
| "During a 12-month study, 42 adult patients with febrile neutropenia (granulocytes < 1 x 10(9)/l) were treated with once-daily gentamicin (5 mg/kg)." | 3.69 | Audit of once-daily dosing gentamicin therapy in neutropenic fever. ( Cooke, RP; Gover, PA; Grace, RJ, 1997) |
| " We conclude that neutropenic patients form a target group for successful pharmacokinetic intervention and cost saving." | 1.30 | Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies. ( Armstrong, VW; Binder, C; Binder, L; Erichsen, N; Hiddemann, W; Menke, CF; Oellerich, M; Schiel, X; Schüttrumpf, S; Unterhalt, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vinker-Shuster, M | 1 |
| Stepensky, P | 1 |
| Temper, V | 1 |
| Shayovitz, V | 1 |
| Masarwa, R | 1 |
| Averbuch, D | 2 |
| Makhoul, R | 1 |
| Rotshild, V | 1 |
| Weintraub, M | 1 |
| Engelhard, D | 1 |
| Amaya, RA | 1 |
| Edwards, MS | 1 |
| Gorschlüter, M | 1 |
| Hahn, C | 1 |
| Fixson, A | 1 |
| Mey, U | 1 |
| Ziske, C | 1 |
| Molitor, E | 1 |
| Horré, R | 1 |
| Sauerbruch, T | 1 |
| Marklein, G | 1 |
| Schmidt-Wolf, IG | 1 |
| Glasmacher, A | 1 |
| Yombi, JC | 1 |
| Wallemacq, P | 1 |
| Leal, T | 1 |
| Gala, JL | 1 |
| Vandercam, B | 1 |
| Ritchie, S | 1 |
| Palmer, S | 1 |
| Ellis-Pegler, R | 1 |
| Cooke, RP | 1 |
| Grace, RJ | 1 |
| Gover, PA | 1 |
| Binder, L | 1 |
| Schiel, X | 1 |
| Binder, C | 1 |
| Menke, CF | 1 |
| Schüttrumpf, S | 1 |
| Armstrong, VW | 1 |
| Unterhalt, M | 1 |
| Erichsen, N | 1 |
| Hiddemann, W | 1 |
| Oellerich, M | 1 |
1 review available for gentamicin and Hematologic Malignancies
| Article | Year |
|---|---|
Agrobacterium radiobacter bacteremia in pediatric patients: case report and review.
Topics: Bacteremia; Catheterization, Central Venous; Child; Device Removal; Drug Therapy, Combination; Femal | 2003 |
3 trials available for gentamicin and Hematologic Malignancies
| Article | Year |
|---|---|
Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome.
Topics: Adolescent; Allografts; Bacteremia; Child; Child, Preschool; Drug Combinations; Drug Resistance, Bac | 2019 |
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cost-Benefit Analysi | 2003 |
Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Area Under Curve; Female; Fever; Gentamicins; Hematolog | 2005 |
4 other studies available for gentamicin and Hematologic Malignancies
| Article | Year |
|---|---|
Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters, Indwellin | 2008 |
High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; Catheterization; Cefepime; Cephal | 2007 |
Audit of once-daily dosing gentamicin therapy in neutropenic fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Marrow Diseases; Drug Admini | 1997 |
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cephalosporins; Dru | 1998 |